Neurovascular mechanisms of Alzheimer's neurodegeneration

Trends in Neurosciences

Volumn 28, Issue 4, 2005, Pages 202-208

  Zlokovic, Berislav V ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; INSULINASE; MATRIX METALLOPROTEINASE; MEMBRANE METALLOENDOPEPTIDASE; METAL CHELATE; PLASMIN; PRION PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

ALZHEIMER DISEASE; ANGIOGENESIS; APOPTOSIS; ASTROCYTE; ATHEROSCLEROSIS; BLOOD BRAIN BARRIER; BRAIN ARTERY; BRAIN BLOOD VESSEL; BRAIN CAPILLARY; BRAIN ISCHEMIA; BRAIN PERFUSION; HUMAN; INFLAMMATION; MICROGLIA; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PIA ARTERY; PRIORITY JOURNAL; REVIEW; SENESCENCE;

EID: 13544268809     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2005.02.001     Document Type: Review

References (69)

1. A. Alzheimer Uber eine eigenartig Erkrankung der Hirnrinde Allg. Z. Psychiatrie Psych. Ger. Med. 64 1907 146 148
2. P.J. Nestor Advances in the early detection of Alzheimer's disease Nat. Med. 10 2004 S34 S41
3. A. Verkhratsky Aging in the mind Trends Neurosci. 27 2004 577 578
4. C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease Nat. Rev. Neurosci. 5 2004 347 360
5. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
6. R.E. Tanzi Clearance of Alzheimer's Aβ peptide: the many roads to perdition Neuron 43 2004 605 608
7. D. Paris Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis Neurosci. Lett. 366 2004 80 85
8. D. Paris Inhibition of angiogenesis by Aβ peptides Angiogenesis 7 2004 75 85
9. P.R. Hof, and J.H. Morrison The aging brain: morphomolecular senescence of cortical circuits Trends Neurosci. 27 2004 607 613
10. T.L. Bailey The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease Neurol. Res. 26 2004 573 578
11. J.C. de la Torre Alzheimer's disease is a vasocognopathy: a new term to describe its nature Neurol. Res. 26 2004 517 524
12. P.B. Gorelick Risk factors for vascular dementia and Alzheimer's disease Stroke 35 2004 2620 2622
13. I. Casserly, and E. Topol Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins Lancet 363 2004 1139 1146
14. A.E. Roher Atherosclerosis of cerebral arteries in Alzheimer's disease Stroke 35 2004 2623 2627
15. W. Kalback Atherosclerosis, vascular amyloidosis and brain hypoperfusion n the pathogenesis of sporadic Alzheimer's disease Neurol. Res. 26 2004 525 539
16. S.M. Greenberg Amyloid angiopathy-related vascular cognitive impairment Stroke 35 2004 2616 2619
17. H.V. Vinters, and E.S. Farag Amyloidosis of cerebral arteries Adv. Neurol. 92 2003 105 112
18. E. Farkas, and P.G. Luiten Cerebral microvascular pathology in aging and Alzheimer's disease Prog. Neurobiol. 64 2001 575 611
19. B.V. Zlokovic Clearing amyloid through the blood-brain barrier J. Neurochem. 89 2004 807 811
20. J. Davis Early-onset and robust cerebral microvascular accumulation of amyloid β-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid β-protein precursor J. Biol. Chem. 279 2004 20296 20306
21. R. Deane LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms Neuron 43 2004 333 344
22. McComb, J.G. and Zlokovic, B.V. (2000) Cerebrospinal fluid and the blood-brain interface. In Textbook of Pediatric Neurosurgery: Physiology of the Child's Central Nervous System, pp. 180-198, W.B. Saunders
23. D.J. Begley, and M.W. Brightman Structural and functional aspects of the blood-brain barrier Prog. Drug Res. 61 2003 39 78
24. R. Balabanov Role of the CNS microvascular pericyte in the blood-brain barrier Neurosci. Res. 53 1998 637 644
25. S.W. Lee SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier Nat. Med. 9 2003 900 906
26. M. Zonta Neuron-to-astrocyte signaling is central to the dynamic control of brain microcirculation Nat. Neurosci. 6 2003 43 50
27. C.M. Anderson, and M. Nedergaard Astrocyte-mediated control of cerebral microcirculation Trends Neurosci. 26 2003 340 344
28. E.A. Newman New roles for astrocytes: Regulation of synaptic transmission Trends Neurosci. 26 2003 536 542
29. M. Nedergaard New roles for astrocytes: Redefining the functional architecture of the brain Trends Neurosci. 26 2003 523 530
30. R. Deane RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain Nat. Med. 9 2003 907 913
31. 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation Proc. Natl. Acad. Sci. U. S. A. 97 2000 9735 9740
32. W.E. Van Nostrand Pathogenic effects of D23N Iowa mutant amyloid β-protein J. Biol. Chem. 276 2001 32860 32866
33. T. Thomas β-Amyloid-mediated vasoactivity and vascular endothelial damage Nature 380 1996 168 171
34. C. Iadecola SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein Nat. Neurosci. 2 1999 157 161
35. S.Y. Bookheimer Patterns of brain activation in people at risk for Alzheimer's disease N. Engl. J. Med. 343 2000 450 456
36. S.E. Vermeer Silent brain infarcts and the risk of dementia and cognitive decline N. Engl. J. Med. 348 2003 1215 1222
37. D.A. Snowdon Healthy aging and dementia: findings from the Nun Study Ann. Intern. Med. 139 2003 450 454
38. R.B. DeMattos Potential role of endogenous and exogenous Aβ binding molecules in Aβ clearance and metabolism T. Saido Aβ Metabolism in Alzheimer's Disease 2003 Landes Bioscience 123 139
39. J.R. Cirrito In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-associated changes in amyloid-β metabolism and half-life J. Neurosci. 23 2003 8844 8853
40. T. Kawarabayashi Age-dependent changes in brain, CSF, and plasma amyloid β protein in the Tg2576 transgenic mouse model of Alzheimer's disease J. Neurosci. 21 2001 372 381
41. R.B. DeMattos Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease Science 295 2002 2264 2267
42. Y. Matsuoka Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid J. Neurosci. 23 2003 29 33
43. C.C. Lemere Alzheimer's disease Aβ reduces central nervous system Aβ levels in a non-human primate, the Caribbean vervet Am. J. Path. 165 2004 283 297
44. Y.M. Kuo High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer's disease Biochem. Biophys. Res. Commun. 257 1999 787 791
45. 1-40 peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier J. Clin. Invest. 106 2000 1489 1499
46. A.M. Fagan Human and murine apoE markedly influence aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease Neurobiol. Dis. 9 2002 305 318
47. R.B. DeMattos ApoE and clusterin cooperatively suppress Aβ levels and deposition: evidence that apoE regulates extracellular Aβ metabolism in vivo Neuron 41 2004 193 202
48. N. Iwata Metabolic regulation of brain Aβ by neprilysin Science 292 2001 1550 1552
49. D.J. Selkoe Clearing the brain's amyloid cobwebs Neuron 32 2001 177 180
50. T. Wyss-Coray Adult mouse astrocytes degrade amyloid-β in vitro and in situ Nat. Med. 9 2003 453 457
51. M. Koistinaho Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides Nat. Med. 10 2004 719 726
52. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nat. Med. 9 2003 653 660
53. Z. Kokaia, and O. Lindvall Neurogenesis after ischaemic brain insults Curr. Opin. Neurobiol. 13 2003 127 132
54. L. Hayflick The illusion of cell immortality Br. J. Cancer 83 2000 841 846
55. T. Minamino Vascular cell senescence and vascular aging J. Mol. Cell. Cardiol. 36 2004 175 183
56. I.D. Auerbach Smooth muscle cells and the pathogenesis of cerebral microvascular disease ('angiomyopathies') Exp. Mol. Pathol. 74 2003 148 159
57. G.D. Silverberg Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis Lancet Neurol. 2 2003 506 511
58. D. Schenk Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 1999 173 177
59. J.A.R. Nicoll Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report Nat. Med. 9 2003 448 452
60. H. Guo Activated protein C prevents neuronal apoptosis via protease activated receptors 1 and 3 Neuron 41 2004 563 572
61. T. Cheng Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective Nat. Med. 9 2003 338 342
62. D. Liu Tissue plasminogen activator neurovascular toxicity is controlled by activated protein C Nat. Med. 10 2004 1379 1383
63. M. Roth The natural history of mental disorder in old age J. Mental Sci. 101 1955 281 301
64. A. Hofman Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam study Lancet 349 1997 151 154
65. B.V. Zlokovic Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer's disease amyloid-β at the blood-brain and blood-cerebrospinal fluid barriers Proc. Natl. Acad. Sci. U. S. A. 93 1996 4229 4234
66. B.J. Bacskai Non-Fc-mediated mechanisms are involved in the clearance of amyloid-β in vivo by immunotherapy J. Neurosci. 22 2002 7873 7878
67. R.B. DeMattos Plaque-associated disruption of CSF and plasma amyloid-β equilibrium in a mouse model of Alzheimer's disease J. Neurochem. 81 2002 229 236
68. F.C. Lam β-Amyloid efflux mediated by p-glycoprotein J. Neurochem. 76 2001 1121 1128
69. C.V. Zerbinatti Increased soluble amyloid β peptide and memory deficits in amyloid model mice overexpressing the LDL receptor-related protein Proc. Natl. Acad. Sci. U. S. A. 101 2004 1075 1080